Hamm John M. 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Hamm John M.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-03-16$5.46/sh−5,930$32,378→ 20,073 total - Award
Options (right to buy)
2025-03-17$5.17/sh+2,750$14,218→ 15,250 totalExercise: $5.17From: 2029-03-17Exp: 2035-03-17→ Common Stock (2,750 underlying)
Footnotes (1)
- [F1]This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.